---
title: "LYONS-WILLIAMS LORI — Ownership Dossier"
canonical: https://whiteintel.dev/entity/165a1909-383c-5053-baae-e4155e56f07f
json: https://whiteintel.dev/api/public/dossier/165a1909-383c-5053-baae-e4155e56f07f
identifier: sec:0001693564
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LYONS-WILLIAMS LORI

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001693564`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/165a1909-383c-5053-baae-e4155e56f07f  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/165a1909-383c-5053-baae-e4155e56f07f  

## Ownership & control

### Holdings / subsidiaries

- **Contineum Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/133dd096-0412-55dd-9c60-de26ff4eae33
- **RAPT Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/4f0433a4-5bee-5850-8bbd-9658cd44fdf7
- **FIVE PRIME THERAPEUTICS INC** (director) — https://whiteintel.dev/entity/9aff28e2-4669-58d2-ac70-a8796893d4c8
- **DERMIRA, INC.** (officer) — https://whiteintel.dev/entity/703e030f-786e-5f44-85db-e876c7bde5a0

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LYONS-WILLIAMS LORI**. Human view: https://whiteintel.dev/entity/165a1909-383c-5053-baae-e4155e56f07f · Structured JSON: https://whiteintel.dev/api/public/dossier/165a1909-383c-5053-baae-e4155e56f07f._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._